SMAD4 and renal cell carcinoma: Although some studies have attempted to evaluate the role of SMAD4 and TGF-β signaling in RCCs (40), little has been uncovered on the associations between SMAD4 expression and its clinical significance to RCC subtypes and the detailed mechanism of SMAD4 inhibition in renal CSC.